# FDA Inspection 766142 - Lowell General Hospital-Saints Campus - February 02, 2012

Source: https://www.keypedia.com/records/fda_inspections/lowell-general-hospital-saints-campus/07d5b967-e82a-489c-a66d-9f689895c2df
Source feed: FDA_Inspections

> FDA Inspection 766142 for Lowell General Hospital-Saints Campus on February 02, 2012. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 766142
- Company Name: Lowell General Hospital-Saints Campus
- Inspection Date: 2012-02-02
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 821662 - 2013-03-05](https://www.keypedia.com/records/fda_inspections/lowell-general-hospital-saints-campus/0817687e-7167-4500-87ab-503d2b3b27ae)
- [FDA Inspection 684200 - 2010-10-06](https://www.keypedia.com/records/fda_inspections/lowell-general-hospital-saints-campus/63416da5-4269-4d81-ad3d-8fb558084ca8)
- [FDA Inspection 601765 - 2009-07-31](https://www.keypedia.com/records/fda_inspections/lowell-general-hospital-saints-campus/6254bd33-bf8d-455c-934a-421904bc8a49)

Company: https://www.keypedia.com/companies/lowell-general-hospital-saints-campus/d12dd831-40c1-48cb-8dfb-d84017a5a6c9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d